400mcg Sublingual Misoprostol as First Line Treatment

NCT01939457 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
641
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Gynuity Health Projects